Over the past two decades, successful therapeutic cardiovascular disease strategies have focused primarily on lowering bad cholesterol (LDL) with statins, and reducing the risk of the blood clots that cause heart attacks or strokes with “blood thinners” such as aspirin. Blood pressure medications are also widely used. Despite these interventions, a significant number of patients experience recurrent events or disease progression.
New research using large clinical trials points strongly to the role of chronic inflammation as a culprit. The studies also show the need for treatments that provide multiple cardiovascular health benefits — optimization of total cholesterol, LDL, blood pressure, triglycerides and inflammation.
New dietary supplements that support this broader cardiovascular inflammatory health approach are available. Dietary supplements that successfully target inflammatory health may also provide support for joint health, liver health, kidney health, metabolic health and cognitive health.
Drugs being developed that address multiple cardiovascular health issues may offer further reduction of the risk of heart attacks, strokes and other major cardiovascular events. New drug treatments that result in the systemic reductions of inflammation may also have a positive impact on other chronic diseases caused by inflammation — including diabetes, arthritis, cancer and Alzheimer’s.